Surgery Partners (SGRY) Cash from Financing Activities (2014 - 2026)

Surgery Partners has reported Cash from Financing Activities for 13 years, with the latest figure at -$55.9 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 285.1% year-over-year to -$55.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$143.4 million (down 155.05% YoY) and the FY2025 annual result came in at -$57.3 million, down 121.87% from the prior year.
• Cash from Financing Activities slipped to -$55.9 million in Q1 2026 per SGRY's latest filing, from $59.2 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $193.1 million in Q4 2022 and troughed at -$84.1 million in Q3 2025.
• A 5-year average of $2.1 million and a median of -$41.2 million in 2023 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities jumped 486.94% in 2024, then tumbled 1052.05% in 2025.
• Over 5 years, Cash from Financing Activities stood at $193.1 million in 2022, then slumped by 123.1% to -$44.6 million in 2023, then soared by 207.62% to $48.0 million in 2024, then increased by 23.33% to $59.2 million in 2025, then slumped by 194.43% to -$55.9 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$55.9 million, $59.2 million, and -$84.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.